Trial · NCT02082769
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Liver function test abnormalities | Hepatobiliary disorders | Febuxostat 40 mg QD | 17 | 168 | 17 |
| other | Liver function test abnormalities | Hepatobiliary disorders | Febuxostat 80 mg QD | 22 | 168 | 22 |
| other | Liver function test abnormalities | Hepatobiliary disorders | Allopurinol 100mg QD | 18 | 168 | 18 |
| other | Renal function test abnormalities | Renal and urinary disorders | Febuxostat 40 mg QD | 2 | 168 | 2 |
| other | Renal function test abnormalities | Renal and urinary disorders | Febuxostat 80 mg QD | 7 | 168 | 7 |
| other | Renal function test abnormalities | Renal and urinary disorders | Allopurinol 100mg QD | 2 | 168 | 2 |
| other | Abnormal electrocardiogram | Cardiac disorders | Febuxostat 40 mg QD | 4 | 168 | 4 |
| other | Abnormal electrocardiogram | Cardiac disorders | Febuxostat 80 mg QD | 0 | 168 | 0 |
| other | Abnormal electrocardiogram | Cardiac disorders | Allopurinol 100mg QD | 1 | 168 | 1 |
| other | Abnormal urine protein | Renal and urinary disorders | Febuxostat 40 mg QD | 4 | 168 | 4 |
| other | Abnormal urine protein | Renal and urinary disorders | Febuxostat 80 mg QD | 4 | 168 | 4 |
| other | Abnormal urine protein | Renal and urinary disorders | Allopurinol 100mg QD | 1 | 168 | 1 |
| other | Drug allergy | Skin and subcutaneous tissue disorders | Febuxostat 40 mg QD | 3 | 168 | 3 |
| other | Drug allergy | Skin and subcutaneous tissue disorders | Febuxostat 80 mg QD | 1 | 168 | 1 |
| other | Drug allergy | Skin and subcutaneous tissue disorders | Allopurinol 100mg QD | 5 | 168 | 5 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Febuxostat 40 mg QD | 3 | 168 | 3 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Febuxostat 80 mg QD | 2 | 168 | 2 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Allopurinol 100mg QD | 4 | 168 | 4 |
| other | Others | General disorders | Febuxostat 40 mg QD | 12 | 168 | 12 |
| other | Others | General disorders | Febuxostat 80 mg QD | 10 | 168 | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02082769/events